Want to join the conversation?
Diagnostics solutions provider $PKI exceeded revenue and profitability expectations for 1Q16 despite a mixed macroeconomic environment. The company grew organic revenue by approx. 4% which was fairly evenly split between Human Health and Environmental Health. Adjusted EPS increased by 12% in 1Q16.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.